Skip to main content

Peer Review reports

From: Validation of risk assessment scores in predicting venous thromboembolism in patients with lung cancer receiving immune checkpoint inhibitors

Original Submission
19 Feb 2024 Submitted Original manuscript
12 Apr 2024 Reviewed Reviewer Report
2 Jul 2024 Reviewed Reviewer Report - Arianna Marinello
14 Jul 2024 Author responded Author comments - Dan Liu
Resubmission - Version 2
14 Jul 2024 Submitted Manuscript version 2
18 Jul 2024 Author responded Author comments - Dan Liu
Resubmission - Version 3
18 Jul 2024 Submitted Manuscript version 3
22 Jul 2024 Author responded Author comments - Dan Liu
Resubmission - Version 4
22 Jul 2024 Submitted Manuscript version 4
16 Aug 2024 Author responded Author comments - Dan Liu
Resubmission - Version 5
16 Aug 2024 Submitted Manuscript version 5
24 Aug 2024 Author responded Author comments - Dan Liu
Resubmission - Version 6
24 Aug 2024 Submitted Manuscript version 6
31 Aug 2024 Author responded Author comments - Dan Liu
Resubmission - Version 7
31 Aug 2024 Submitted Manuscript version 7
Publishing
3 Oct 2024 Editorially accepted
10 Oct 2024 Article published 10.1186/s12890-024-03323-z

You can find further information about peer review here.

Back to article page